BG
RGNX icon

BlackRock Group’s Regenxbio RGNX Stock Holding History

BlackRock Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$60K Buy
+3,222
New +$61.6K ﹤0.01% 2895
2016
Q2 		– Sell
-19,194
Closed -$207K – 3043
2016
Q1 		$207K Hold
19,194
– – ﹤0.01% 2569
2015
Q4 		$319K Hold
19,194
– – ﹤0.01% 2374
2015
Q3 		$423K Buy
+19,194
New +$490K ﹤0.01% 2267

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock Group's RGNX Position: Q4 2016 in Review

BlackRock Group opened a new position in Regenxbio (RGNX) in Q4 2016: 3,222 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #2895 among its holdings. This is a return to the name: BlackRock Group previously reported a position in RGNX as recently as Q1 2016.

BlackRock Group first reported a position in RGNX in Q3 2015 and has held it in 4 quarters since. The position peaked at $423K in Q3 2015. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

  • BlackRock Group held 3,222 shares of Regenxbio worth $60K as of Q4 2016.
  • Regenxbio was a new BlackRock Group position in Q4 2016.
  • Regenxbio made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2895 holding.
  • BlackRock Group first reported a position in Regenxbio in Q3 2015 and has held it in 4 quarters since.
  • BlackRock Group's Regenxbio position peaked at $423K in Q3 2015.
  • 78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.